Welcome to CDC stacks | Adventitious viral genomes in vaccines but not in vaccinees. - 15073 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Adventitious viral genomes in vaccines but not in vaccinees.
  • Published Date:
    2001 Jan-Feb
  • Source:
    Emerg Infect Dis. 7(1):153-154.
Filetype[PDF-38.05 KB]


Details:
No Related Documents.
You May Also Like:
  1. Adventitious Agents and Live Viral Vectored Vaccines: Considerations for Archiving Samples of Biological Materials for Retrospective Analysis
    Personal Author:
    Klug, Bettina; Robertson, James S.; Condit, Richard C.; Seligman, Stephen J.; Laderoute, Marian P.; Sheets, Rebecca; Williamson, Anna-Lise; Chapman, Louisa E.; Carbery, Baevin; Mac, Lisa M.; Chen, Robert T.;
    Corporate Author:
    Brighton Collaboration Viral Vaccine Vector Safety Working Group
    Published:
    Jun 15 2016
    Source:
    Vaccine. 34(51):6617-6625.
    Description:
    Vaccines are one of the most effective public health medicinal products with an excellent safety record. As vaccines are produced using biological materials, there is a need to safeguard against potential contamination with adventitious agents. Adven...
    File Type:
    Filetype[PDF - 91.74 KB]
  2. Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients.
    Personal Author:
    Hussain, Althaf I.; Shanmugam, Vedapuri.; Switzer, William M.; Tsang, Shirley X.; Fadly, Aly.; Thea, Donald.; Helfand, Rita.; Bellini, William. J.; Folks, Thomas M.; Heneine, Walid.;
    Published:
    2001 Jan-Feb
    Source:
    Emerg Infect Dis. 7(1):66-72.
    Description:
    The identification of endogenous avian leukosis virus (ALV) and endogenous avian retrovirus (EAV) in chick cell-derived measles and mumps vaccines in current use has raised concern about transmission of these retroviruses to vaccine recipients. We us...
    File Type:
    Filetype[PDF - 134.57 KB]
  3. No Evidence of Murine Leukemia Virus-Related Viruses in Live Attenuated Human Vaccines
    Personal Author:
    Switzer, William M.; Zheng, HaoQiang.; Simmons, Graham.; Zhou, Yanchen.; Tang, Shaohua.; Shankar, Anupama.; Kapusinszky, Beatrix.; Delwart, Eric L.; Heneine, Walid.;
    Published:
    Dec 22 2011
    Source:
    PLoS One. 2011; 6(12).
    Description:
    Background : The association of xenotropic murine leukemia virus (MLV)-related virus (XMRV) in prostate cancer and chronic fatigue syndrome reported in previous studies remains controversial as these results have been questioned by recent data. Nonet...
    File Type:
    Filetype[PDF - 278.99 KB]
  4. Developing new smallpox vaccines.
    Personal Author:
    Rosenthal, S. R.; Merchlinsky, M.; Kleppinger, C.; Goldenthal, K. L.;
    Published:
    2001 Nov-Dec
    Source:
    Emerg Infect Dis. 7(6):920-926.
    Description:
    New stockpiles of smallpox vaccine are required as a contingency for protecting civilian and military personnel against deliberate dissemination of smallpox virus by terrorists or unfriendly governments. The smallpox vaccine in the current stockpile ...
    File Type:
    Filetype[PDF - 40.71 KB]
  5. Live Virus Vaccines Based on a Yellow Fever Vaccine Backbone: Standardized Template with Key Considerations for a Risk/Benefit Assessment*
    Personal Author:
    Monath, Thomas P.; Seligman, Stephen J.; Robertson, James S.; Guy, Bruno; Hayes, Edward B.; Condit, Richard C.; Excler, Jean Louis; Mac, Lisa Marie; Carbery, Baevin; Chen, Robert T;
    Corporate Author:
    The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)
    Published:
    Oct 27 2014
    Source:
    Vaccine. 33(1):62-72.
    Description:
    The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety of live, recombinant viral vaccines incorporating genes from heterologous viruses inserted into the backbone of another virus (so-called "...
    File Type:
    Filetype[PDF - 323.46 KB]